Navigation Links
Beyond the microscope: Identifying specific cancers using molecular analysis
Date:3/19/2012

SALT LAKE CITY, March 19, 2012Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report they have discovered a method to identify cancer-causing rearrangements of genetic material called chromosomal translocations quickly, accurately, and inexpensively. A description of the method and the research results appear online in this month's issue of the EMBO Molecular Medicine journal.

Many cancers result from chromosomal translocations in tumor cells. Hundreds of cancer-causing translocations have been discovered, but current methods for detecting them have significant shortcomings.

The technique, developed in the lab of Stephen Lessnick, M.D., Ph.D., director of the Center for Children's Cancer Research at HCI, combines microarray technology, which can look for thousands of translocations in a single test, with a novel antibody that is used to detect the presence of the translocation.

"We're moving past the age when a pathologist looking through the microscope at a tumor sample is the best way to diagnose what type of cancer it is," said Lessnick. "The molecular tests currently available are slow, inefficient, and expensive, and one of the biggest issues is that you need high-quality tumor samples, not always available in the clinical setting, to do them." According to Lessnick, his method tolerates real-life specimens much better than the current standard techniques.

"Originally, this method was used in HCI's Cairns lab (headed by Bradley R. Cairns, Ph.D.) to study RNA in yeast. We took their method and applied it to our study of chromosomal translocations in human tissue," Lessnick said. He said the next task is to find a commercial partner to develop this research from a 'proof of principle' into a diagnostic test that doctors can use to help their patients.

"With this method, there's potential to develop a single array that could test for every known cancer-causing translocation simultaneously. Currently, a clinician has to decide beforehand which specific cancer to test," he said.

The research used Ewing's sarcoma (a rare childhood cancer) as the case study for developing the method, but Lessnick maintains that the technology can be easily applied to any type of cancer caused by a translocation.

Funding for this project came from the National Institutes of Health's Innovative Molecular Analysis Technology program. The program focuses on rapid movement of new ideas from basic science labs (such as the Cairns lab) out into the clinical realm. "They were willing to fund this idea without a lot of preliminary data because it showed good potential to move toward clinical uses," said Lessnick.


'/>"/>

Contact: Linda Aagard
801-587-7639
University of Utah Health Sciences
Source:Eurekalert

Related biology news :

1. Car tracks beyond the asphalt
2. Beyond Darwin: Evolving new functions
3. Stranglers of the tropics -- and beyond
4. Biodiversity science in Quebec: 2010 and beyond
5. Beyond polar bears? Experts look for a new vision of climate change to combat skepticism
6. Beyond the genome
7. Beyond the corn field: Balancing fuel, food and biodiversity
8. Homebuilding beyond the abyss
9. Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
10. Beyond genomics, biologists and engineers decode the next frontier
11. Frost & Sullivan Looks at Biometrics Advancement in Civil Security: Exploring Opportunities for Today and Beyond
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016 Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases ... from Vigilant Solutions. Brian Wenberg explains, ... victim was walking out of a convenience store and witnessed an elderly male ... vehicle, striking his vehicle and leaving the scene.  In ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... ( www.wocketwallet.com ) announces the launch of a new video featuring singer, ... Las Vegas , where Joey appeared at the Wocket booth to ... , where Joey appeared at the Wocket booth to meet and greet ... the Consumer Electronics Show (CES2016) in Las Vegas , ... --> --> The video is ...
Breaking Biology News(10 mins):
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, ... with the first pluripotent stem cell-derived islet replacement ... in clinical-stage development, today announced that ViaCyte and ... Companies of Johnson & Johnson, have agreed to ... into ViaCyte.  The agreement provides ViaCyte with an ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 ... ), a biotechnology company developing bioengineered organ implants ... bronchus, today announced that CEO Jim McGorry ... & Investor Conference on Tuesday, February 9, ... New York City . HART,s presentation will ...
(Date:2/3/2016)... ... February 03, 2016 , ... StarNet Communications Corp, ... today announced the addition of a powerful “Session Preview” feature to its FastX ... state of the remote Linux desktop or other applications (sessions) they have running ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... in the rapid development and ongoing quality control of molecular assays targeting the ... extremely high,” Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix, relayed to ...
Breaking Biology Technology: